Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $22.87M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| ACXP | ACURX PHARMACEUTICALS INC | $6.80M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| IOBT | IO BIOTECH INC | $23.91M | 65,880,914 | 26.58% | 73.42% | Net Buying | |||
| KALA | KALA BIO INC | $9.87M | 6,452,398 | 6.74% | 93.26% | Net Buying | |||
| FEMY | FEMASYS INC | $9.59M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| ATYR | ATYR PHARMA INC | $64.17M | 89,004,436 | 74.54% | 17.28% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $38.73M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| GOVX | GEOVAX LABS INC | $12.00M | 25,359,593 | 0.21% | 99.79% | Net Buying | Net Buying | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $77.01M | 17,661,698 | 29.13% | 25.91% | ||||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $28.77M | 57,542,105 | 11.22% | 38.43% | Net Selling | |||
| SGMO | SANGAMO THERAPEUTICS INC | $203.05M | 301,709,485 | 16.98% | 10.66% | Net Selling | Net Selling | ||
| FGEN | FIBROGEN INC | $49.54M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $67.50M | 99,264,526 | 0.38% | 23.66% | Net Buying | Net Buying | ||
| GRI | GRI BIO INC | $5.18M | 2,515,305 | 0.71% | 99.29% | ||||
| NRXP | NRX PHARMACEUTICALS INC | $65.03M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $37.27M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| MDCX | MEDICUS PHARMA LTD | $41.24M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| PMN | PROMIS NEUROSCIENCES INC | $22.28M | 51,806,497 | 16.36% | 49.79% | Net Buying | |||
| OSTX | OS THERAPIES INC | $62.51M | 31,891,933 | 1.89% | 20.70% | Net Selling | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.81M | 23,858,301 | 10.74% | 60.23% | ||||
| MTVA | METAVIA INC | $22.75M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.21M | 1,919,441 | 4.26% | 95.74% | Net Buying | |||
| CING | CINGULATE INC | $21.22M | 5,412,523 | 3.75% | 96.25% | ||||
| INTS | INTENSITY THERAPEUTICS INC | $11.44M | 47,057,727 | 4.20% | 4.44% | Net Buying | |||
| KAPA | KAIROS PHARMA LTD | $24.27M | 20,743,765 | 1.05% | 32.68% | Net Buying | |||
| LSTA | LISATA THERAPEUTICS INC | $22.53M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.14M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| MYO | MYOMO INC | $33.72M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $25.09M | 68,003,613 | 21.00% | 15.70% | ||||
| JSPR | JASPER THERAPEUTICS INC | $38.68M | 16,253,332 | 20.42% | 79.58% | Net Buying | Net Buying | ||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | 82,674,725 | 7.82% | 0.00% | ||||
| SLN | SILENCE THERAPEUTICS PLC | $244.90M | 141,701,848 | 13.95% | 0.09% | ||||
| NOTE | FISCALNOTE HOLDINGS INC | $66.44M | 14,349,995 | 30.70% | 69.30% | Net Selling | Net Selling | ||
| IPSC | CENTURY THERAPEUTICS INC | $43.02M | 86,389,098 | 26.19% | 48.12% | Net Selling | Net Selling | ||
| IMUX | IMMUNIC INC | $84.51M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| MBRX | MOLECULIN BIOTECH INC | $16.05M | 30,286,168 | 1.43% | 20.90% | Net Buying | |||
| PASG | PASSAGE BIO INC | $25.53M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Buying | ||
| TIL | INSTIL BIO INC | $120.57M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.92M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| ACET | ADICET BIO INC | $66.99M | 82,709,625 | 62.39% | 19.44% | Net Selling | |||
| ATOS | ATOSSA THERAPEUTICS INC | $111.99M | 129,171,424 | 16.53% | 11.04% | Net Buying | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.40M | 2,611,788 | 0.26% | 99.74% | ||||
| ANVS | ANNOVIS BIO INC | $40.34M | 19,486,231 | 9.30% | 15.63% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $275.13M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| SNTI | SENTI BIOSCIENCES INC | $36.77M | 26,081,139 | 20.78% | 79.22% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.